Loading...
[(89)Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study
Recent studies on immune-mediated inflammatory lung diseases show encouraging treatment results with rituximab, a monoclonal antibody (mAb) against CD20-expressing B lymphocytes. The present pilot study aimed to explore the possibility to image CD20-expression in the lungs as future early predictor...
Na minha lista:
| Udgivet i: | Am J Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
e-Century Publishing Corporation
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6971479/ https://ncbi.nlm.nih.gov/pubmed/31976159 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|